Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

277 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multidrug resistance in lung cancer.
Broxterman HJ, Versantvoort CH, Linn SC. Broxterman HJ, et al. Among authors: linn sc. Cancer Treat Res. 1995;72:193-222. doi: 10.1007/978-1-4615-2630-8_10. Cancer Treat Res. 1995. PMID: 7702987 Review. No abstract available.
Prognostic relevance of P-glycoprotein expression in breast cancer.
Linn SC, Giaccone G, van Diest PJ, Blokhuis WM, van der Valk P, van Kalken CK, Kuiper CM, Pinedo HM, Baak JP. Linn SC, et al. Ann Oncol. 1995 Sep;6(7):679-85. doi: 10.1093/oxfordjournals.annonc.a059284. Ann Oncol. 1995. PMID: 8664189 Free article.
[Young adults with Ewing's sarcoma].
Kerst JM, Van Coevorden F, Peterse J, Haas RL, Linn SC. Kerst JM, et al. Among authors: linn sc. Ned Tijdschr Geneeskd. 2004 Jul 3;148(27):1355-8. Ned Tijdschr Geneeskd. 2004. PMID: 15283029 Dutch.
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.
Berns K, Horlings HM, Hennessy BT, Madiredjo M, Hijmans EM, Beelen K, Linn SC, Gonzalez-Angulo AM, Stemke-Hale K, Hauptmann M, Beijersbergen RL, Mills GB, van de Vijver MJ, Bernards R. Berns K, et al. Among authors: linn sc. Cancer Cell. 2007 Oct;12(4):395-402. doi: 10.1016/j.ccr.2007.08.030. Cancer Cell. 2007. PMID: 17936563 Free article. Clinical Trial.
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).
Bueno-de-Mesquita JM, van Harten WH, Retel VP, van 't Veer LJ, van Dam FS, Karsenberg K, Douma KF, van Tinteren H, Peterse JL, Wesseling J, Wu TS, Atsma D, Rutgers EJ, Brink G, Floore AN, Glas AM, Roumen RM, Bellot FE, van Krimpen C, Rodenhuis S, van de Vijver MJ, Linn SC. Bueno-de-Mesquita JM, et al. Among authors: linn sc. Lancet Oncol. 2007 Dec;8(12):1079-1087. doi: 10.1016/S1470-2045(07)70346-7. Epub 2007 Nov 26. Lancet Oncol. 2007. PMID: 18042430
277 results